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Definitions of words and terms 
Acute disease or injury related malnutrition: protein energy malnutrition caused by factors 
related to acute disease or an injury in the presence of a high degree of inflammation. 
Cachexia: a complex syndrome which presents with the loss of body weight, predominately 
skeletal muscle, as a result of metabolic abnormalities related to disease processes. 
Disease related malnutrition: protein energy malnutrition caused by disease related processes 
in the presences of a mild to moderate degree of inflammation. 
Protein energy malnutrition: a syndrome caused by the inadequate bioavailability of energy 
and/or protein over time, leading to the catabolism of lean tissues with or without loss of fat 
mass, occurring most frequently in older adults. 
Sarcopenia: The loss of muscle mass, strength and function that occurs in ageing. 
Starvation-related malnutrition: Protein energy malnutrition due to pure chronic starvation 
or anorexia nervosa; but is also affected by social, environmental, physical and psychological 
risk factors. 
  
Summary points (5 – 15) 
1. Protein-energy malnutrition, a syndrome caused by the inadequate bioavailability of 
energy and/or protein over time, leading to the catabolism of lean tissues with or without 
loss of fat mass, occurring most frequently in older adults. 
2. Inadequate energy and protein intake in malnutrition can be caused by not consuming 
sufficient dietary sources of energy and protein to meet an individual’s nutrient 
requirements, which is exacerbated in states of hypermetabolism, and/or not absorbing 
the energy or protein consumed. This is further impacted by psychological, 
environmental, social and economic risk factors. 
3. Malnutrition causes systemic catabolism of fat mass and lean tissues, including vital 
organs of the liver, heart, respiratory system and skeletal muscle mass. 
4. Simple starvation is a physiological state referring to the metabolic alterations, such as 
hypophosphatemia and the production of ketones as the primary energy source, which 
are activated in a state of food and nutrient deprivation, but when it causes physiological 
consequences it is clinically referred to as malnutrition. 
5. Starvation-related malnutrition is due to pure chronic starvation or anorexia nervosa; but 
is also affected by social, environmental, physical and psychological risk factors. 
6. During extended starvation, several organ systems modify their metabolism. Liver 
gluconeogenesis decreases the production of glucose and kidney production of glucose 
increases. Fat loss also occurs in starvation-related malnutrition which provides a more 
stable energy source than glucose produced by gluconeogenesis.  
7. Sarcopenia is the loss of muscle mass, strength and function that occurs in ageing. 
8. The aetiology of age-related sarcopenia is multifactorial. Declines in nutritional intake, 
malabsorption of nutrients, reduced physical activity levels, progressive and irreversible 
loss of motor neurons, although normal in ageing, result in loss of muscle mass and 
function. 
9. Sarcopenia has a significant impact on the independence of older adults, and is also 
known to increase the risk of depression and type II diabetes. 
10. Cachexia is a complex syndrome which presents with the loss of body weight, 
predominately skeletal muscle, as a result of metabolic abnormalities related to disease 
processes. 
11. Conditions which predispose to cachexia and disease-related malnutrition are those that 
present with systemic inflammation including cancer, chronic infection, chronic kidney 
disease, chronic obstructive pulmonary disease, acquired immune deficiency syndrome, 
rheumatoid arthritis, chronic heart failure and liver failure. 
12. Cachexia also significantly increases the risk of death beyond the rate seen in standard 
protein-energy malnutrition, and is one of the primary causes of death in cancer. 
  
Abstract 
Wasting syndromes such as malnutrition, starvation, sarcopenia and cachexia have been 
increasingly recognised in healthcare and are the subject of significant research endeavours 
internationally. It is the purpose of this chapter to compare the characteristics (definitions and 
diagnosis, aetiology and outcomes) of each of these conditions in older adults. Protein-energy 
malnutrition, a syndrome caused by the inadequate bioavailability of energy and/or protein over 
time, leading to the catabolism of lean tissues with or without loss of fat mass, occurring most 
frequently in older adults. Malnutrition prevalence ranges from 10 – 50% depending on the 
setting. Simple starvation is a physiological state referring to the metabolic alterations, such as 
hypophosphatemia and the production of ketones as the primary energy source, which are 
activated in a state of food and nutrient deprivation, but when it causes physiological 
consequences it is clinically referred to as malnutrition. Starvation-related malnutrition is only 
diagnosed when protein energy malnutrition is caused by food and nutrient deprivation over a 
long period time in the absence of disease processes and inflammation. Sarcopenia is the loss of 
muscle mass, strength and function that occurs due to age-related changes in physiology, and 
ranges in prevalence from 10 – 50% depending on age group. Cachexia is a complex syndrome 
which presents with the loss of body weight, predominately skeletal muscle, as a result of 
metabolic abnormalities related to disease processes. Cachexia may be considered as a type of 
disease-related malnutrition, and ranges in prevalence from 10 – 50% depending on the 
underlying disease. Malnutrition, starvation, sarcopenia and cachexia result in the catabolism 
and resulting dysfunction of multiple organ systems and skeletal muscle, leading to poor patient 
outcomes such as physical dysfunction, hospitalisations, poor quality of life, and increased risk 
of death.  
  
Chapter 
Introduction 
In1974 Dr Charles Edwin Butterworth Jr’s put the first spotlight on wasting syndromes in older 
adults when he published “The Skeleton in the Hospital Closet” (Butterworth Jr, 1974). Since 
then, wasting syndromes such as malnutrition, sarcopenia and cachexia have been increasingly 
recognised in healthcare and are the subject of significant research endeavours internationally 
(Krumdieck, 1998). However, despite over 40 years of research aimed at improving the 
nutritional status of older adults, malnutrition, sarcopenia and cachexia remain highly prevalent 
worldwide in the community, hospitals and residential aged care (Watterson et al., 2009). In 
addition, there is significant confusion in the literature and in clinical practice between 
malnutrition, starvation, sarcopenia and cachexia (Tzankoff and Norris, 1978). Therefore, it is the 
purpose of this chapter to explore the current evidence regarding the definition and diagnosis, 
aetiology, and outcomes of each of these conditions in older adults. 
 
  
Malnutrition in older adults 
Definition and diagnosis 
The term “malnutrition” traditionally refers to any state of an individual resulting from the 
inadequate and/or excessive intake of nutrients. Each nutrient has a range of intake that is 
required for optimal health, and an intake below or above this is associated with impaired 
physical function (2005). However, overtime the term “malnutrition” has come to be frequently 
used to refer to “protein-energy malnutrition” (PEM), a syndrome caused by the inadequate 
bioavailability of energy and/or protein over time, leading to the catabolism of lean tissues with 
or without loss of fat mass, occurring most frequently in older adults (2008). Other nutrients may 
also be deficient; however, the lack of sufficient energy and/or protein is the defining aetiological 
characteristic of PEM (2015). However, there is no international consensus on the definition of 
PEM, nor even its name, as it is also referred to as “protein-energy undernutrition” or “protein-
calorie malnutrition”. The loss of lean tissues (comprising 35 – 50% of total body weight) with 
or without fat mass presents clinically as decreased body weight, evidence of muscle wasting 
and compromised homeostasis in organ function, blood cells and immune cells (Pleuss, 2005).  
Reflecting this variable clinical presentation, there is no single measure able to diagnose PEM. 
Instead, a diagnosis is reached through a global examination by a highly-trained health 
professional of an individual’s medical status, anthropometry, biochemistry, dietary intake, 
nutrition-related symptoms and a physical examination. To support this process, health 
professionals frequently use a “nutrition assessment tool” to gather the required information and 
to guide interpretation. Although not all clinicians and researchers utilise a nutrition assessment 
tool to make a diagnosis of PEM, it is considered best-practice to do so, and is increasingly 
required in health care facilities (Watterson et al., 2009). There are three nutrition assessment 
tools which are validated for use in older adults, these are the Mini Nutritional Assessment 
(MNA) (Guigoz and Vellas, 1997), the Subjective Global Assessment (SGA) (Detsky et al., 
1987) and Scored Patient-Generated Subjective Global Assessment (PG-SGA) (Marshall et al., 
2016b). 
Protein-energy malnutrition may also be defined and diagnosed by its severity and cause. 
Reflecting the amount of body weight lost and/or severity of muscle wasting in a certain time-
frame, PEM an individual may be categorised as “mildly malnourished”, “moderately 
malnourished” or “severely malnourished”. However, there is also no consensus as to how each 
of these categories is defined, and usually is based upon the nutrition assessment tool utilised or 
the amount of weight lost in a certain period.  
In 2012, the Academy of Nutrition & Dietetics (AND) and the American Society for Parenteral 
and Enteral Nutrition (ASPEN) reached a consensus on the set of aetiology-based diagnostic 
characteristics for PEM (White et al., 2012). There were three aetiology-based diagnostic criterion 
agreed upon, which are outlined in Figure 1. Beyond these three categories, the consensus 
definition also categorises PEM as severe or nonsevere (moderate), based on the degree of 
inadequate energy intake, weight loss, fat loss, muscle wasting, fluid accumulation and grip 
strength (White et al., 2012). 
 
 
Figure 1: Consesus aetiology-based protein-energy malnutriton definitions (adapted from 
(White et al., 2012)).  
Legend: The characteristics of the three sub-types of protein-energy malnutrition, which differ 
primarily on the cause of malnutrition. AIDS, acquired immune deficiency syndrome.  
Aetiology 
Protein-energy malnutrition is a condition that develops over time, with a latency period ranging 
from days to years depending on the initial nutritional state of the individual and the severity of 
malnutrition-causing symptoms and environments. Inadequate energy and protein can be caused 
by: 1) not consuming sufficient dietary sources of energy and protein to meet an individual’s 
nutrient requirements, which is exacerbated in states of hypermetabolism, or 2) not absorbing 
the energy or protein consumed. Additionally, it should be highlighted that in any one person, 
there may be one or many contributing causes.  
Starvation 
related 
malnutrition
•No inflammation present
•Pure chronic starvation
•Example causes: anorexia nervosa, nil. by mouth
Chronic-disease 
related 
malnutrition
•Mild to moderate inflammation
•Chronic disease leading cause of inadequate 
energy and protein availability
•Example causes: cancer, liver failure, AIDS
Acute disease 
or injury related 
malnutrition
•Significant inflammation
•Acute disease or injury leading cause of 
inadequate energy and protein availability
•Example causes: sepsis, trauma, major surgery 
There are innumerable causes of inadequate energy and protein dietary intake, examples of 
which are shown in figure 2. When hypermetabolism is present, the bodies demand for energy 
and protein increases significantly, and may in some cases double (Marshall, 2017, 2005). This 
is often confounded by a low level of nutrition knowledge, where older adults may fail to 
recognise increased nutrient requirements or the types of foods required to prevent malnutrition 
(Marshall et al., 2016a). Similarly, not absorbing the consumed energy and protein also has 
diverse causes, including: 
1. Diseases related to maldigestion and malabsorption. Examples are short bowel syndrome, 
gastrointestinal catabolism as a result of malnutrition, gastritis, inflammatory bowel syndrome, 
cystic fibrosis, pancreatic and liver diseases, and bariatric surgery. 
2. Diseases related to excessive nutrient losses. Examples are diarrhoea, steatorrhoea, vomiting, 
protein losing enteropathy, surgical drains, stomas, fistulae, haemodialysis and blood loss. 
 
Figure 2: Social, environmental, physical and psychological factors which decrease a person’s 
ability to consume adequate energy and protein (Marshall, 2017).  
Legend: These are diverse and overlapping risk factors which increase the chances that an older 
adult will consume less energy and protein in their food, which in turn increases the chances 
they will become malnourished.   
Physical
•Hypermetabolism, e.g. cancer, respiratory 
disease, steroids, burns, infection
•Decreased appetite, e.g. medications, nausea, 
pain, dementia, drug additictions, anorexia of 
ageing, food aversions
•Inability to eat: e.g. dysphasia, confusion, poor 
food  preparation skills, poor dentition, 
medical restrictions, blindness, vomiting
Psychological
• Mental illness, e.g. depression, psychosis, 
dementia, eating disorders
•Social anxiety, e.g. self-consciousness, bullying 
•Self-percieved health status
Environmental
•Rurality: decreased food and health care 
access
•Socio-economic status
•Country and region
•Access to basic living requirements, e.g. 
transport, telephone
Social
•Financial insecurity
•Social isolation and eating alone
•Ethnicity
•Health beliefs
•Informal care networks
•Level of education
Inadquate energy & protein intake
Prevalence 
The prevalence of PEM varies widely according to the setting and the geographical location; but 
also varies according to the age group of a sample as well as the diagnostic tool used. Cereda 
and associates recently published a meta-analysis of PEM prevalence, diagnosed by the MNA, 
in older adults (>60 years) according to healthcare setting (Cereda et al., 2016). The highest 
prevalence was found in long-term care (29%; n=23 studies) and rehabilitation and sub-acute 
care (29%, n=15 studies), followed by acute care (22%, n=66 studies) and nursing homes (18%, 
n=44 studies), then home care services (9%, n=15 studies), out-patients (6%, n=37 studies) and 
the community (3%, n=58 studies) (Cereda et al., 2016). Additionally, this meta-analysis found 
that the prevalence of PEM, according to the MNA, was consistently and significantly higher in 
European countries as opposed to Asian countries across all settings, although other 
geographical locations were not described for comparison (Cereda et al., 2016). 
However, reviews and diagnostic studies have found that the MNA considers fewer patients as 
malnourished than other tools including the SGA, PG-SGA and ICD, and therefore true PEM 
prevalence may be higher (Marshall, 2016, Marshall et al., 2016b).  
The impact of rurality on the prevalence of malnutrition has not been evaluated in a meta-
analysis; however, a review in the rehabilitation and sub-acute setting found that the highest 
prevalence was found to in be rural settings (53-65% in rural Australia; 32 – 49% in urban 
Australia; all measured using the SGA)(Marshall, 2016).  
There are many social, cultural, economic and physical changes that occur in ageing, which 
increases the risk of protein-energy malnutrition; where many of the risk factors outlined in 
Figure 2 are more likely to occur in older adults. Research has consistently found age to be a risk 
factor for increasing risk of malnutrition (Agarwal et al., 2012). In Europe (n=15,043 
participants, n=325 hospitals, n=25 countries), every 10 years of life was found to increase risk 
of PEM by 14% (OR:1.14 [95%CI:1.09-1.19]; P<0.0001).  
Outcomes  
The physiological and psychosocial consequences of malnutrition are significant and diverse 
(Agarwal et al., 2016). Confusion, fatigue and weakness, common symptoms of malnutrition, 
are often attributed to other conditions leading to frequent misdiagnosis and under-recognition 
of malnutrition (Wellman and Kamp, 2008). Malnutrition causes systemic catabolism of fat mass 
and lean tissues, including vital organs of the liver, heart, respiratory system and skeletal muscle 
mass (Figures 3, 4 and 5). Catabolism of these lean tissues cause a disruption in homeostasis in 
nearly all physiological systems, leading to diverse health outcomes (Figures 3, 4 and 5). In 
addition to those shown in Figures 3, 4 and 5, malnutrition also causes fluid and electrolyte 
imbalances which may further affect kidney and cardiac function. The combination of 
decreasing physical function in multiple organ systems as a result of malnutrition increases risk 
of mortality. Malnutrition has been found to be an independent risk factor for death, with studies 
finding the risk of death doubled in hospital (RR: 2.63 [95%CI: 1.55-5.27] P<0.05) (Correia and 
Waitzberg, 2003) (OR: 1.92 [95%CI: 1.09-3.34] P=0.023) (Agarwal et al., 2013) and more than 
tripled in the year following discharge (HR: 3.41 [95%CI: 1.07-10.87] P=0.038) (Charlton et al., 
2012). 
As would be expected with such significant poor health outcomes, individuals who are 
malnourished may experience a lower quality of life, apathy, depression, self-neglect, 
hypochondriasis, poor self-efficacy, poor body image, confusion, decreased interest in food, loss 
of libido and engage less frequently in social activities (2006, Bottone et al., 2012, Marshall et 
al., 2014). Additionally, these poor health outcomes caused by malnutrition contribute a 
significant economic burden, where the cost of treating a patient with malnutrition in the UK is 
more than double the cost of treating a well-nourished patient due to the increase use of health-
related resources (Guest et al., 2011). Using data on healthcare utilisation by people with 
malnutrition, it was recently estimated that the cost of treating the health problems associated 
with malnutrition in the UK is in excess of £13 billion (AUD$23 billion) per year (Elia and 
Stratton, 2005). In the USA, disease-related malnutrition in the community setting was found to 
have an annual burden of USD$156.7 billion (AUD$214.7 billion) to society, the large majority 
of which was due to medical complications associated with malnutrition (Snider et al., 2014). In 
order to offset the great patient and economic burden, it is essential that the condition is 
addressed by a multidisciplinary team with the support of the health care system, the community 
and society in general.  
 
 
 
 Figure 3: The physiological process and health outcomes related to liver catabolism as a 
consequence of protein-energy malnutrition (2006, Stratton et al., 2003, Pleuss, 2005, Ferreira 
et al., 2011, Martyn et al., 1998). 
Legend: This figure describes how the breakdown of liver mass and function which occurs in 
malnutrition will have increased risk of impaired wound healing, infection, swelling, pressure 
sores and anaemia.  
 
Catabolism of 
liver protein
•Inhibition of 
liver protein 
synthesis
Decreased liver 
cells circulating 
blood stream
•↓ Immune cells
•↓ Albumin
•↓ Haemoglobin
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Poor health 
outcomes
•Impaired wound healing
•Infection risk
•Oedema
•Pressure ulcers
•Anaemia
Catabolism of 
skeletal muscle 
& fat mass
Decreased 
muscle mass 
and strength
Poor health 
outcomes
•Worse physical function
•Falls & fracture risk
•Impaired thermoregulation
•Disability
•Pressure ulcers
•Thromboembolism risk
Figure 4: The physiological process and health outcomes related to skeletal muscle and fat mass 
catabolism as a consequence of protein-energy malnutrition (2006, Stratton et al., 2003, Pleuss, 
2005, Ferreira et al., 2011, Martyn et al., 1998). 
Legend: This figure describes how the breakdown of muscles and loss of fat which occurs in 
malnutrition will have increased risk of impaired physical function, falls and fractures, body 
temperature regulation, pressure sores and obstruction of blood flow. 
 
 
 
Figure 5: The physiological process and health outcomes related to respiratory and cardiac 
muslce catabolism as a consequence of protein-energy malnutrition (2006, Stratton et al., 2003, 
Pleuss, 2005, Ferreira et al., 2011, Martyn et al., 1998). 
Legend: This figure describes how the breakdown of the heart and lungs which occurs in 
malnutrition will have increased risk of lung infections and water retention, fatigue, low blood 
pressure, poor coughing, and other heart problems.  
 
 
 
 
Catabolism of cardiac 
& respiratory muscle
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Starvation in older adults 
Definition and diagnosis 
Simple starvation is a physiological state referring to the metabolic alterations, such as 
hypophosphatemia and the production of ketones as the primary energy source, which are 
activated in a state of food and nutrient deprivation, but when it causes physiological 
consequences it is clinically referred to as malnutrition (Gallagher, 2008, Litchford, 2008). Some 
definitions of starvation are analogous to PEM; that is, a chronic inadequate intake of protein 
and energy, causing a loss of both fat-mass and fat-free mass (Thomas, 2007); which is reflected 
in starvation being one of the aetiology-based definitions of PEM (Figure 1). Starvation-related 
malnutrition is only diagnosed when PEM is caused by food and nutrient deprivation over a long 
period time in the absence of disease processes and inflammation (White et al., 2012).  
Extended periods of starvation may also lead to marasmus, another form of malnutrition also 
called adapted starvation defined as uncomplicated starvation without inflammation (Gallagher, 
2008, Litchford, 2008). Again, this definition of marasmus, or adapted starvation, is analogous 
to starvation-related malnutrition. Starvation may also refer to the deprivation of particular 
nutrients, for example, the deprivation of protein when carbohydrate is regularly consumed may 
lead to kwashiorkor, which is also a form of malnutrition characterised by hypalbuminaemia 
(Gallagher, 2008). Overall, starvation may be an important component of malnutrition in some 
clinical situations, but starvation-related malnutrition should be used as a clinical diagnosis to 
enhance consistency in terminology across health care facilities and disciplines (White et al., 
2012). 
Aetiology 
Starvation-related malnutrition (Figure 1) is due to pure chronic starvation or anorexia nervosa 
(White et al., 2012). The social, environmental, physical and psychological factors which cause 
PEM (Figure 2), may also be the cause of starvation-related malnutrition. One of these 
physiological causes that occurs in older adults is referred to as the “anorexia of ageing”, which 
refers to little to no dietary intake related to the decreased appetite which occurs as part of normal 
ageing (Visvanathan, 2003). Appetite is controlled by interactions between the cortex, limbic 
system and midbrain as well as peripheral inputs from the gut, adipose tissue and endocrine 
system (Visvanathan, 2003). These processes may work less efficiently with increasing age 
leading to consumption of a less varied and lower quality diet (Visvanathan, 2003). However, 
poor appetite leading to starvation and subsequently weight loss and/or malnutrition is not part 
of the normal ageing process and is preventable (Huffman, 2002). 
Prevalence 
There is no data regarding the prevalence of starvation-related malnutrition as opposed to PEM 
in general. However, starvation-related malnutrition may be more likely to be the type of PEM 
found in older adults living in the community, as malnutrition diagnosed in health care facilities 
is likely to be acute, disease or injury-related associated with the reasons for admission. 
Outcomes  
After several days of starvation, the gastrointestinal tract begins to atrophy, reducing its 
absorptive capacity; however, with recommencement of nutrient intake, absorptive capacity is 
returned within a few days (Beyer, 2008). During extended starvation, several organ systems 
modify their metabolism. Liver gluconeogenesis decreases the production of glucose and kidney 
production of glucose increases. The substrates used in liver gluconeogenesis originate from 
skeletal muscle, which releases glycogenic amino acids, pyruvate and lactate to be used for 
gluconeogenesis via the Cori cycle (Gallagher, 2008). In the renal gluconeogenesis, the 
glutamine released by skeletal muscle is deaminated to alpha-keoglutarate which is used to 
produce glucose (Gallagher, 2008).  
Apart from catabolism of lean tissues such as skeletal muscle, fat loss also occurs in starvation-
related malnutrition which provides a more stable energy source than glucose produced by 
gluconeogenesis (Gallagher, 2008). During starvation, low insulin levels allow fatty acids to be 
released from adipocytes and transported to the liver, where they form ketones. Ketones then 
enter the blood stream and are able to be used as an energy source (Gallagher, 2008). 
These processes reveal the varying clinical presentation in starvation-related malnutrition as 
opposed to forms caused by injury or disease; where starvation-related malnutrition more 
typically presents with low fat and muscle mass, but other forms of malnutrition may occur with 
a the loss of lean tissues only (White et al., 2012). 
In terms of poor health outcomes, these are the same for starvation-related malnutrition and PEM 
in general; excepting outcomes related to low fat mass such as increased fracture risk, may be 
more common {Stratton et al., 2003}. 
  
Sarcopenia in older adults 
Definition and diagnosis 
The term “sarcopenia”, derived from the Greek words ‘sarx’ (flesh) and ‘penia’ (loss), was 
coined by Professor Irwin Rosenberg in 1989 to describe age-related loss of muscle mass 
(Baumgartner et al., 1998).  Eventually, with improved understanding of sarcopenia, loss of 
muscle quality, strength and function or ‘dynapenia’ were also linked with loss of muscle mass 
(Morley et al., 2014). Under the auspices of four international working groups, namely European 
Working Group on Sarcopenia in Older People (EWGSOP), the European Society for Clinical 
Nutrition and Metabolism Special Interest Groups (ESPEN-SIG), the International Working 
Group on Sarcopenia (IWGS), and the Society of Sarcopenia, Cachexia and Wasting Disorders, 
consensus definitions of sarcopenia were released (Table 1) (Cruz-Jentoft et al., 2010, Fielding 
et al., 2011, Morley et al., 2011, Muscaritoli et al., 2010). These consensus definitions led to 
sarcopenia being recently recognised as a disease entity in the International Classification of 
Diseases with its own unique ICD-10 code (Anker et al., 2016).  
Table 1. Consensus definitions of Sarcopenia 
Working group Definition 
European Working Group on 
Sarcopenia in Older People 
(EWGSOP) (Cruz-Jentoft et 
al., 2010) 
The presence of: 
 Low skeletal muscle mass AND 
 Low muscle strength (e.g., handgrip) OR  
 Low muscle performance assessed by walking speed or muscle 
power 
The presence of all three conditions indicates ‘severe’ 
sarcopenia.  
International Working Group 
on Sarcopenia (IWGS) 
(Fielding et al., 2011) 
The presence of 
 Low skeletal muscle mass AND 
 Low muscle function assessed by walking speed AND/OR  
 Increased fat mass 
 
Society of Sarcopenia, 
Cachexia and Wasting 
Disorders (Morley et al., 2011) 
The presence of 
 Loss of muscle mass AND 
 Limited mobility in the absence of specific diseases of muscle, 
peripheral vascular disease, disorders of the central and 
peripheral nervous system, or cachexia.  
European Society for Clinical 
Nutrition and Metabolism 
Special Interest Groups 
The presence of: 
 Low skeletal muscle mass AND 
 Low muscle strength assessed by walking speed 
(ESPEN-SIG) (Muscaritoli et 
al., 2010) 
 
Legend: There is no perfect or completely accepted definition of sarcopenia. These are the 
different recognised definitions put forth by various organisations. EWGSOP, European 
Working Group on Sarcopenia in Older People; ESPEN-SIG, European Society for Clinical 
Nutrition and Metabolism Special Interest Groups; IWGS, International Working Group on 
Sarcopenia. 
All four definitions call for the quantification of muscle mass and muscle strength along with 
measuring deficits in muscle function (Scharf and Heineke, 2012). Currently, several parameters 
are available to measure age-related sarcopenia. A summary of available diagnostic methods 
along with advantages and limitations has been summarised in Table 2. With the development 
of its own unique disease classification code, it is extremely important for identifying the most 
suitable biomarker for correctly diagnosing, monitoring and treating sarcopenia (Scharf and 
Heineke, 2012).   
 
 
 
 
 
 
 
 
 
 
 
Table 2. Diagnosis of sarcopenia (adapted from (Scharf and Heineke, 2012, Yu et al., 2016)) 
 Method Description Advantages Limitation 
Imaging-related 
quantification 
of muscle mass 
Magnetic Resonance Imaging 
(MRI) 
Calculates segmental and 
total muscle mass; assesses 
muscle quality through 
assessing fat infiltration in 
muscle; quantifies oedema 
and visceral organs 
High quality image 
resolution; accurately 
quantifies and determines 
quality of whole-body and 
regional adipose tissue and 
skeletal muscle tissue; safe 
Expensive; requires 
specialised setting, trained 
staff and specific software; 
time-intensive; non-portable 
Computed Tomography (CT) Reconstructs image when x-
ray attenuation through 
tissues is detected; identifies 
adipose tissue, skeletal 
muscle, bone, visceral 
organs and brain tissue 
High quality image 
resolution; accurately 
quantifies and determines 
quality of body composition 
at tissue-organ level; 
identifies total and regional 
adipose tissue and skeletal 
muscle tissue 
Expensive; requires 
specialised setting, trained 
staff and specific software; 
time-intensive; non-portable; 
considerable radiation 
Dual-energy X-ray 
absorptiometry (DEXA) 
Using low radiation x-rays 
can differentiate between 
bone and soft tissue allowing 
for fat mass to be estimated 
from soft tissue; assesses 
bone mineral density  
Determines fat, lean and 
bone tissue for whole body 
and specific regions; non-
invasive, fast; accurate 
Requires specialised setting, 
trained staff and specific 
software; hydration and 
thickness of tissue can 
influence measurements 
Bioelectrical impedance 
analysis (BIA) 
 
Measures total body water to 
estimate fat- and fat-free 
mass 
Portable, simple to use, 
inexpensive, no radiation 
exposure, quick 
Hydration status and 
presence of oedema can 
distort results; limited use in 
those with BMI>34kg/m2 as 
likely to underestimate fat 
mass 
Functional 
Tests for muscle 
performance 
EWGSOP algorithm Measures gait speed and 
handgrip strength 
Low cost; standardised test; 
simple to use 
Results confounded by 
comorbidities (degenerative 
and inflammatory 
conditions); lacks validation 
studies; not useful in patients 
with arthritis in hand 
SARC-F questionnaire Assesses 5 domains: 
strength, independence, 
rising from chair, climbing 
stairs and falls history 
Rapid, cost-effective, no 
measurements required 
Low sensitivity 
Legend: There are various methods available to test if a patient has sarcopenia. This table outlines these, and summarises their benefits and 
limitations. BIA, Bioelectrical impedance analysis CT, Computed Tomography; DEXA, Dual-energy X-ray absorptiometry; EWGSOP; 
European working group on sarcopenia in older people; MRI, Magnetic Resonance Imaging. SARC-F has no full non-abbreviated title.  
 
 
Aetiology 
The aetiology of age-related sarcopenia is multifactorial. Declines in nutritional intake, 
malabsorption of nutrients, reduced physical activity levels, progressive and irreversible loss of 
motor neurons, although normal in ageing, result in loss of muscle mass and function (Cruz-
Jentoft et al., 2010, Malafarina et al., 2012). Older adults confined to bed due to illness or trauma 
are highly prone to loss of muscle mass (Malafarina et al., 2012). Age-related loss of immunity 
causes an increase in inflammatory cytokines and are associated with reduction in muscle mass 
and strength in older adults (Malafarina et al., 2012). Deterioration in levels of hormones such 
as oestrogen, testosterone, and insulin-like growth factors also contribute to the development of 
sarcopenia (Malafarina et al., 2012). Coexisting conditions such as osteoporosis, obesity, and 
type 2 diabetes are also associated with sarcopenia in older adults (Cruz-Jentoft et al., 2010, 
Malafarina et al., 2012).   
Prevalence 
Ageing is associated with a 1% decline in muscle mass per decade from 30 years of age, 
accelerating to approximately 8% loss of muscle mass along with a 10-15% loss of leg strength 
per decade from the age of 40-70 years (Kim and Choi, 2013). After the age of 70 years, this 
escalates to 15% loss in muscle mass and 25-40% loss in leg strength per decade (Kim and Choi, 
2013). Although age-related loss of muscle mass is greater in males, sarcopenia-related loss of 
function and increased disability is greater in women at three-fold versus males at two-fold (Kim 
and Choi, 2013). Sarcopenia has been identified in 1-30% of community-dwelling older adults, 
14-33% of those living in aged care facilities, 10% of those in acute care, and in 50% of those 
aged over 80 years (Cruz-Jentoft et al., 2014). Prevalence of sarcopenia is also noticeably high 
in conditions such as stroke (53%) and hip fractures (71%) due to rapid muscle loss associated 
with denervation and inflammation respectively (Morley et al., 2014).   
Outcomes  
Almost 40% of the total body mass and 75% of the body’s cell mass in comprised of skeletal 
muscle, which has a pivotal role in mobility and function (Lang et al., 2010a). Age-associated 
sarcopenia has major ramifications on health-related outcomes in older adults (Figure 6).  
 Figure 6. Consequences of Sarcopenia (Developed from (Lang et al., 2010b, Rolland et al., 2008)  
Legend: These are the poor health outcomes which can be caused by having the condition of sarcopenia.  
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Cachexia in older adults 
Definition and diagnosis 
Cachexia is a complex syndrome which presents with the loss of body weight, predominately 
skeletal muscle, as a result of metabolic abnormalities related to disease processes (Evans et al., 
2008). The 2008 consensus definition of cachexia is:  
‘‘Cachexia is a complex metabolic syndrome associated with underlying illness and 
characterized by loss of muscle with or without loss of fat mass. The prominent clinical feature 
of cachexia is weight loss in adults (corrected for fluid retention) or growth failure in children 
(excluding endocrine disorders). Anorexia, inflammation, insulin resistance and increased 
muscle protein breakdown are frequently associated with cachexia. Cachexia is distinct from 
starvation, age-related loss of muscle mass, primary depression, malabsorption and 
hyperthyroidism and is associated with increased morbidity.” (Evans et al., 2008) 
Cachexia is further defined by consensus in the form of “cancer cachexia”, the ongoing loss of 
skeletal muscle mass (with or without fat loss) which cannot be fully reversed by nutrition 
support and leads to progressive functional impairment. The loss of lean tissues in cancer 
cachexia is caused by inadequate dietary intake combined with abnormal metabolism (Fearon et 
al., 2011). Cachexia has been further staged into cachexia and pre-cachexia. The consensus 
diagnostic criteria and definition of pre-cachexia according to the 2015 ESPEN consensus paper 
(Muscaritoli et al., 2010) is shown in Figure 6. However, this ESPEN consensus paper did not 
provide diagnostic criteria for cachexia; therefore, the diagnostic criteria and definition of 
cachexia by a 2008 consensus paper is also shown in Figure 7 (Evans et al., 2008). 
There is disagreement in the literature as to whether cachexia is a type of malnutrition (i.e. 
disease-related malnutrition), or is a separate condition. Some consensus publications state 
expert agreement that they are separate conditions, where not all malnourished patients are 
cachectic, but all cachectic patients are malnourished (Muscaritoli et al., 2010). However, this 
statement will still hold true with the acceptance that a cachexia is the same condition as disease-
related malnutrition, as both are caused by disease in the presence of inflammation. This is 
reflected in a more recent consensus statement by ESPEN, which considers disease-related 
malnutrition and cachexia to be essentially the same condition due to the similarities in 
presentation and aetiology. However, it should be noted, that not all persons with chronic-disease 
related malnutrition may be diagnosed as having cachexia, and further clinical examination 
should be undertaken to evaluate the level of inflammation in the individual (Cederholm et al., 
2015). 
 
Figure 7: The consensus definitions and diagnostic criteria of pre-cachexia according to 
Muscaritoli et. al. (Muscaritoli et al., 2010) and cachexia according to Evans et. al. (Evans et 
al., 2008). 
Legend: These are the criteria which help define if a person has pre-cachexia or cachexia.  
Aetiology 
Conditions which predispose to caschexia and disease-related malnutrition are those that present 
with systemic inflammation including cancer, chronic infection, chronic kidney disease, chronic 
obstructive pulmonary disease, AIDS, rheumatoid arthritis, chronic heart failure and liver failure 
(Evans et al., 2008, Muscaritoli et al., 2010).  In cachexia, the loss of skeletal muscle in cachexia 
is a result of increased resting energy expenditure mediated by elevated levels of 
proinflammatory cytokines (e.g. TNF-α, IL-1, IL-6) and decreased anti-inflammatory cytokines 
(e.g. IL-4, IL-12, IL-15) (Bauer et al., 2006, Muscaritoli et al., 2010). This systemic inflammation 
causes metabolic abnormalities including a prolonged acute phase protein response, increased 
muscle proteolysis and impaired lipid, carbohydrate and protein metabolism (Bauer et al., 2006, 
Muscaritoli et al., 2010).  Therefore, cachexia is purported to not respond to typical dietary 
intervention which aims to provide a high protein-high energy diet, and instead other treatment 
approaches are being explored such as omega-3 fatty acids and mixtures of elemental amino 
acids (Dewey et al., 2007, Eley et al., 2007)., and states of malnutrition and sarcopenia have been 
described as a “pre-cachectic state”, where nutritional intervention may have the most benefit 
(Evans et al., 2008). However, some research has shown that nutrition intervention may impact 
upon the pathogenesis of cachexia, although nutrition intervention alone is insufficient to treat 
the condition (Wilson and Morley, 2003, Evans et al., 2008, Isenring and Teleni, 2013).   
Pre-cachexia 
(all criteria must be met)
• Underlying chronic disease
• Unintentional weight loss ≤5% usual 
body weight during past 6-monhts
• Chronic or recurrent systemic 
inflammatory response
• Anorexia or anorexia-related symptoms
Cachexia
(weight loss and 3 of the 5 other criteria 
must be met)
• Weight loss of ≥5% in 12-months (or 
BMI <20kg/m2)
• Decreased muscle strength
• Fatigue
• Anorexia
• Low fat-free mass index
• Abnormal biochemistry (increased 
inflammatory marekrs, anaemia or 
hypoalbuminurea)
Prevalence 
The global prevalence of cachexia is estimated to be 1% of the patient population, which equates 
to approximately 9 million people (von Haehling and Anker, 2014). However, understanding the 
prevalence of cachexia is complicated by the lack of an overall accepted definition and diagnostic 
criteria, as well as most criteria being difficult to assess, such as the need for measurement of 
overall lean body mass (e.g. via DXA scans) and assessment of biochemistry (Tan and Fearon, 
2008). Additionally, the prevalence of cachexia is expected to vastly differ according to the 
underlying disease process (e.g. cancer versus cardiac failure, or pancreatic cancer versus lung 
cancer) and population characteristics. Following a brief review of the literature, the prevalence 
of cachexia as reported in various studies is 10 – 50% (Table 3). 
 
Table 3: The prevalence of cachexia in different disease states and populations. 
Underlying 
disease 
Study Population sample Reported 
prevalence 
Cancer, all types Von Haehling and Stefan, 
2014 (von Haehling and 
Anker, 2014) 
Estimated for entire 
European population. 
30% 
Unresectable 
pancreatic cancer 
Tan and Fearon, 2008 (Tan 
and Fearon, 2008) 
Unclear. 20% 
Resectable 
pancreatic cancer 
Bachmann et al. 2008 
(Bachmann et al., 2008) 
N=277, mean age 64-65 
years, 35% female. 
Germany. 
41% 
Colorectal cancer Thoresen et. al. 2013 
(Thoresen et al., 2013) 
N=77, mean age 63 
years, 47% female. 
Norway & Canada. 
28% 
Chronic 
Obstructive 
Pulmonary 
Disease 
Von Haehling and Stefan, 
2014 (von Haehling and 
Anker, 2014) 
Estimated for entire 
European population. 
35% 
Chronic Heart 
Failure 
Von Haehling and Stefan, 
2014 (von Haehling and 
Anker, 2014) 
Estimated for entire 
European population. 
10% 
Chronic Heart 
Failure 
 Christensen et. al. 2013  N=238. Not further 
described. 
 
11% 
Chronic Heart 
Failure 
Anker et. al. 1997 (Anker 
et al., 1997) 
N=171, mean age 60 
years, 11% female. 
United Kingdom. 
16% 
Severe 
rheumatoid 
arthritis 
Von Haehling and Stefan, 
2014 (von Haehling and 
Anker, 2014) 
Estimated for entire 
European population. 
10% 
End stage chronic 
kidney disease 
Von Haehling and Stefan, 
2014 (von Haehling and 
Anker, 2014) 
Estimated for entire 
European population. 
50% 
Legend: This table reports the prevalence of cachexia, as a percentage of various populations 
with other diseases as specified.  
 
Outcomes  
The loss of lean tissues in cachexia results in the dysfunction of multiple organ systems seen in 
malnutrition (Figures 4, 5 & 6). However, the weight loss in cachexia differs from the weight 
loss in malnutrition; although both are characterised by the loss of lean tissues, the loss of lean 
tissues compared to fat mass is accelerated in cachexia (Bauer et al., 2006). Cachexia also 
significantly increases the risk of death beyond the rate seen in standard protein-energy 
malnutrition, and is one of the primary causes of death in cancer (Bauer et al., 2006). The 
increased risk of death in cachexia may be due to the detrimental effect that decreased lean tissues 
has on the efficacy of medical treatment, such as increased risk of complications, and lower doses 
and duration of chemotherapy (Donohoe et al., 2011).  
Policies and protocols  
National and state-based health services in many countries have a nutrition care policy which 
aims to address geriatric wasting syndromes such as malnutrition, sarcopenia and cachexia. 
Policies for health services typically address nutrition screening and assessment, but may also 
address the provision of food and monitoring systems (2011). In recognition of the high burden 
of malnutrition, the United States of America has mandated compulsory nutrition screening upon 
admission to any health care facility (2017b). In the United Kingdom, although individual health 
services may have policies to manage malnutrition, there is no policy at the national level, and 
instead there is a guidance document (England, 2015). Nutrition policies may also be supported 
by malnutrition pathways or nutrition care protocols, which guide clinicians to implementing 
best-practice, for example the Malnutrition Action Flowchart in Australia (Banks). 
Outside of the health service, there is generally poor development and implementation of 
malnutrition policies in community and residential aged care settings, as each organisation is 
independent and managing malnutrition may not be part of accreditation standards. However, 
there are some facilities which are proactive in addressing this problem and many non-
government organisations have arisen to support implementaiton of malnutrition policies and 
pathways, such as Managing Adult Malnutrition in the Community (Brotherton et al., 2012) and 
the UK and Canadian Malnutrition Task Force (2017c, 2017a).  
Conclusion 
There is ample evidence showing that weight and muscle loss seen in PEM, starvation, 
sarcopenia and cachexia are associated with frailty, loss of independence, poor prognosis and 
increased mortality. Although these conditions present with similar characteristics, differential 
diagnosis is important in the clinical setting so that the patient may be linked with the most 
appropriate treatment, and that new methods of management may be developed. 
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